Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of Dosing Interval of Higher Doses of Ranibizumab

Authors not listed

Brandon G. Busbee, MD · 2007

Abstract

Evaluation of Dosing Interval of Higher Doses of Ranibizumab for patients with wet age-related macular degeneration (AMD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2007). Evaluation of Dosing Interval of Higher Doses of Ranibizumab. <em>Brandon G. Busbee, MD</em>. https://clinicaltrials.gov/study/NCT00533520
Vancouver
Anonymous. Evaluation of Dosing Interval of Higher Doses of Ranibizumab. Brandon G. Busbee, MD. 2007.
BibTeX
@misc{anon2007Evalua, title = {Evaluation of Dosing Interval of Higher Doses of Ranibizumab}, author = {Anonymous}, journal = {Brandon G. Busbee, MD}, year = {2007}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings